Goodness Growth Holdings Closes on Initial $2.0 Million Tranche of $10.0 Million Financing Commitment Psychedelics Investing
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel Pharmaceutical Investing
XTANDI® plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide Life Science Investing
ASLAN Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update Medical Device Investing
Glass Lewis Recommends Aurinia Shareholders Vote "FOR" ALL Company Director Nominees at 2023 Annual Meeting Life Science Investing
Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says Psychedelics Investing
